Page last updated: 2024-10-30

metformin and Infantile Respiratory Distress Syndrome

metformin has been researched along with Infantile Respiratory Distress Syndrome in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"In a south Indian population with gestational diabetes, metformin was associated with better neonatal outcomes than glibenclamide."2.80Comparison of neonatal outcomes in women with gestational diabetes with moderate hyperglycaemia on metformin or glibenclamide--a randomised controlled trial. ( Abraham, A; Antonisamy, B; Beck, M; Benjamin, SJ; George, A; Jana, AK; Mathews, JE; Sam, D; Thomas, N, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
George, A1
Mathews, JE1
Sam, D1
Beck, M1
Benjamin, SJ1
Abraham, A1
Antonisamy, B1
Jana, AK1
Thomas, N1

Trials

1 trial available for metformin and Infantile Respiratory Distress Syndrome

ArticleYear
Comparison of neonatal outcomes in women with gestational diabetes with moderate hyperglycaemia on metformin or glibenclamide--a randomised controlled trial.
    The Australian & New Zealand journal of obstetrics & gynaecology, 2015, Volume: 55, Issue:1

    Topics: Adult; Birth Injuries; Birth Weight; Diabetes, Gestational; Female; Fetal Macrosomia; Glyburide; Hum

2015